Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 1:7:613432.
doi: 10.3389/fmed.2020.613432. eCollection 2020.

Mucocutaneous Manifestations of Behçet's Disease

Affiliations
Review

Mucocutaneous Manifestations of Behçet's Disease

Koichiro Nakamura et al. Front Med (Lausanne). .

Abstract

Behçet's disease (BD) is a chronic, relapsing, systemic inflammatory disease with clinical features showing mucocutaneous lesions involving the ocular, articular, and further miscellaneous organs. Mucocutaneous manifestations, one of the most characteristic signs of BD, have been most commonly observed upon onset or at any disease stage and are exceptionally important in its diagnosis. Given the lack of specific diagnostic laboratory tests for BD, diagnosis has been based on clinical findings. All diagnostic criteria published have thus far relied heavily on mucocutaneous manifestations, particularly oral ulcers (OU), genital ulcers (GU), cutaneous lesions, and pathergy test positivity. Worldwide, OU, GU, cutaneous lesions, and ocular and articular manifestations have been the most common symptoms, with erythema nodosum (EN)-like lesions and papulopustular lesions being the most prevalent cutaneous manifestations. While majority of the patients worldwide have reported OU as the most frequent symptom upon disease onset, GU, and EN-like lesions have also been identified upon onset. Considering that mucocutaneous symptoms precede severe organ involvement in most patients, familiarity with such symptoms is imperative for early diagnosis and prevention of potentially serious organ involvement through appropriate management.

Keywords: Behçet's disease; erythema nodosum-like lesion; genital ulcer; oral ulcer; papulopustular lesion.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Oral ulcer on the buccal mucosa with rolled borders and grayish necrotic base. (B) Genital ulcer with yellowish necrotic tissue on the scrotum. The genital ulcer is deep and surrounded by erythema. The scrotum is the site most commonly involved in the male. (C) Erythema nodosum-like lesions on the lower leg. A painful, reddish erytemanous nodule is detected in the pretibial lesion. (D) Papulopustular folliculitis are sterile pustules on the erythematous base of the trunk. (E) Superficial thrombophlebitis is erythematous tender subcutaneous nodules arranged in a linear fashion on the leg. (F) Histological feature of erythema nodosum-like lesion includes a dense neutrophil infiltrate around the vessels in the subcutaneous tissue. (G) Histological feature of papulopustular lesion includes a leukocytoclastic vasculitis with neutrophil infiltrate in the dermis. (H) Histology of thrombophlebitis shows vascular thrombus and lymphocytic infiltrate in a subcutaneous vein. (I) Skin pathergy reaction is a pustule formation at the needle site after 24 h on the forearm. (A,F,H,I) are derived from Nakamura et al. (3, 4).

References

    1. Yazici H, Seyahi E, Hatemi G, Yazici Y. Behçet's disease: a contemporary view. Nat Rev Rheumatol. (2018) 14:107–19. 10.1038/nrrheum.2017.208 - DOI - PubMed
    1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Eng J Med. (1999) 341:1284–91. 10.1056/NEJM199910213411707 - DOI - PubMed
    1. Nakamura K, Iwata Y, Asai J, Kawakami T, Tsunemi Y, Takeuchi M, et al. . Guidelines for the treatment of skin and mucosal lesions in Behçet's disease: a secondary publication. J Dermatol. (2020) 47:223–35. 10.1111/1346-8138.15207 - DOI - PubMed
    1. Nakamura K, Iwata Y, Asai J, Kawakami T, Tsunemi Y, Takeuchi M, et al. Clinical Features and Algorithm of Treatment. 2020 JSBD Clinical Practice Guidelines for Behçet's Disease. Mizuki N, Takeuchi M, editors. Tokyo: Shindan To Chiro Sha, Inc. (2020). p. 20–3, p. 54–6.
    1. Alpsoy E. Behçet's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. (2016) 43:620–32. 10.1111/1346-8138.13381 - DOI - PubMed